Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

NCT00936065 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Psoriasis

Interventions

DRUG: Etanercept
DRUG: Etanercept + Acitretin
DRUG: Acitretin

Sponsor

Pfizer